AbCellera Biologics (ABCL) Interest & Investment Income (2022 - 2026)
AbCellera Biologics (ABCL) posted Interest & Investment Income of $3.6 million for Q1 2026, down 38.46% on a QoQ basis from $5.9 million in Q4 2025, and down 34.04% year-over-year from $5.5 million in Q1 2025.
AbCellera Biologics (ABCL) Interest & Investment Income (2022 - 2026) Analysis & Trends
AbCellera Biologics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- Quarterly Interest & Investment Income fell 34.04% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.9 million (down 28.8% YoY) and the FY2025 annual result came in at $28.3 million, down 26.37% from the prior year.
- Interest & Investment Income was $3.6 million for Q1 2026 at AbCellera Biologics, down from $5.9 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $11.0 million in Q4 2023 and bottomed at $665000.0 in Q1 2022.
- A 5-year average of $7.4 million and a median of $8.5 million in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 1367.52% — and 2025, when it sank 46.9%.
- AbCellera Biologics' Interest & Investment Income stood at $8.5 million in 2022, then rose by 29.5% to $11.0 million in 2023, then decreased by 20.98% to $8.7 million in 2024, then plunged by 31.7% to $5.9 million in 2025, then slumped by 38.46% to $3.6 million in 2026.
- Business Quant data shows ABCL's Interest & Investment Income at $3.6 million in Q1 2026, $5.9 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | AbCellera Biologics | 1.62 Bn | 1.62 Bn | - | 3.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.64 Mn |
| Dec 31, 2025 | 5.92 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Jun 30, 2025 | 7.59 Mn |
| Mar 31, 2025 | 5.52 Mn |
| Dec 31, 2024 | 8.67 Mn |
| Sep 30, 2024 | 9.60 Mn |
| Jun 30, 2024 | 9.80 Mn |
| Mar 31, 2024 | 10.40 Mn |
| Dec 31, 2023 | 10.97 Mn |
| Sep 30, 2023 | 10.74 Mn |
| Jun 30, 2023 | 10.78 Mn |
| Mar 31, 2023 | 9.76 Mn |
| Dec 31, 2022 | 8.47 Mn |
| Sep 30, 2022 | 5.56 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 665,000.00 |